• Company
• Expectations rise for the reimbursement of Phesgo in Korea
• by Whang, byung-woo Oct 4, 2024 04:38am

• Company
• Biologics seek to expand indications…is approved for COPD
• by Son, Hyung Min Oct 4, 2024 04:38am

• Company
• "Importance of fungal infections TX amid COVID-19 spike"
• by Son, Hyung Min Oct 4, 2024 04:38am

• Company
• Imfinzi builds evidence for biliary tract cancer reimb
• by Whang, byung-woo Oct 2, 2024 05:49am

• Policy
• EUA for Novavax's COIVD-19 vaccine targeting the variant
• by Lee, Hye-Kyung Oct 2, 2024 05:49am

• Product
• ‘Disclose the pricing rationale used for COVID-19 drugs'
• by Kang, Hye-Kyung Oct 2, 2024 05:49am

• Company
• Will the Imfinzi·Imjudo combo be reimb within the year?
• by Eo, Yun-Ho Oct 2, 2024 05:49am

• Company
• "Expanded scope for the newborn screening test"
• by Whang, byung-woo Oct 2, 2024 05:48am

• Company
• Jardiance generics prepare for final launch in Korea
• by Kim, Jin-Gu Sep 30, 2024 05:47am

• Policy
• "Hundreds of doctors have received pharmaceutical rebates"
• by Kang, Shin-Kook Sep 30, 2024 05:47am